CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...

On 2 July, the EU Commission officially announced its strategy which aims to make Europe a global leader in quantum by 2030 ...